Please enable JavaScript to continue using this application.

Compare $ANAB vs $ORIC | Chartloom

Compare

$ANAB vs $ORIC

AnaptysBio Inc · Oric Pharmaceuticals Inc

ANAB

AnaptysBio Inc

ORIC

Oric Pharmaceuticals Inc

Compare $ANAB vs $ORIC

Comparing AnaptysBio Inc and Oric Pharmaceuticals Inc

ANABAnaptysBio Inc

ORICOric Pharmaceuticals Inc

ANABAnaptysBio Inc

Market cap

$1.36B

P/E (TTM)

14.99x

Forward P/E (NTM)

16.38x

Forward P/S (NTM)

10.95x

Rev growth (TTM)

92.9%

YTD performance

2.2%

52W performance

44.4%

FCF yield

1.3%

ORICOric Pharmaceuticals Inc

Market cap

$1.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

46.8%

52W performance

-16.0%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANAB

ORIC

Detailed metrics comparison

ANAB

AnaptysBio Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

ANAB$1.36B

ORIC$1.24B

Enterprise Value

ANAB$1.48B

ORIC$1.20B

Price

ANAB$45.95

ORIC$11.99

P/E Ratio

ANAB14.99x

ORICN/A

P/S Ratio

ANAB5.73x

ORIC0.00x

EV/Sales

ANAB6.24x

ORIC0.00x

EV/EBITDA

ANAB10.83x

ORIC0.00x

P/B Ratio

ANAB137.06x

ORIC3.32x

P/FCF Ratio

ANAB75.37x

ORICN/A

EV/FCF

ANAB82.17x

ORIC-10.72x

PEG Ratio

ANABN/A

ORICN/A

Forward P/E (NTM)

ANAB16.38x

ORICN/A

Forward P/S (NTM)

ANAB10.95x

ORICN/A

Revenue (TTM)

ANAB$238M

ORIC$0

Revenue Growth (YoY)

ANAB92.9%

ORICN/A

Forward Rev Growth

ANAB34.7%

ORIC1520.7%

Gross Margin (TTM)

ANAB0.0%

ORIC0.0%

Operating Margin (TTM)

ANAB56.4%

ORIC0.0%

EBITDA Margin (TTM)

ANAB56.5%

ORIC0.0%

Net Margin (TTM)

ANAB82.4%

ORIC0.0%

FCF Margin (TTM)

ANAB7.6%

ORICN/A

Net Income (TTM)

ANAB$196M

ORIC$-140M

FCF (TTM)

ANAB$18M

ORIC$-112M

EPS (TTM)

ANAB$3.07

ORIC-$1.30

ROE (TTM)

ANAB895.0%

ORIC-3535.0%

ROA (TTM)

ANAB57.4%

ORIC-3339.0%

ROIC (TTM)

ANAB63.2%

ORIC-3535.0%

Cash

ANAB$134M

ORIC$37M

Debt

ANAB$256M

ORIC$0

Net Cash/Debt

ANAB$-123M

ORIC$37M

Current Ratio (TTM)

ANAB5.61x

ORIC13.19x

Quick Ratio (TTM)

ANAB5.54x

ORIC12.76x

Debt/Equity (TTM)

ANAB24.23x

ORIC0.00x

Debt/Assets (TTM)

ANAB0.0%

ORIC0.0%

Interest Coverage (TTM)

ANABN/A

ORICN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

ORIC0.00x

Beta

ANAB0.82

ORIC1.13

52W Performance

ANAB44.4%

ORIC-16.0%

YTD Performance

ANAB2.2%

ORIC46.8%

% from 52W High

ANAB-37.3%

ORIC-18.3%

% from 52W Low

ANAB51.8%

ORIC65.8%

Asset Turnover (TTM)

ANAB0.70x

ORIC0.00x

FCF Yield (TTM)

ANAB1.3%

ORIC-9.0%

Earnings Yield (TTM)

ANAB14.4%

ORIC-11.3%

Dividend Yield (TTM)

ANABN/A

ORICN/A

Rule of 40

ANAB100.5

ORIC0.0

EV/GP/RG

ANABN/A

ORICN/A

Ticker research

View ANAB research View ORIC research

Metric	ANAB AnaptysBio Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.36B	$1.24B
Enterprise Value	$1.48B	$1.20B
Price	$45.95	$11.99
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	3.32x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	N/A
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-140M
FCF (TTM)	$18M	$-112M
EPS (TTM)	$3.07	-$1.30
ROE (TTM)	895.0%	-3535.0%
ROA (TTM)	57.4%	-3339.0%
ROIC (TTM)	63.2%	-3535.0%
Financial Health
Cash	$134M	$37M
Debt	$256M	$0
Net Cash/Debt	$-123M	$37M
Current Ratio (TTM)	5.61x	13.19x
Quick Ratio (TTM)	5.54x	12.76x
Debt/Equity (TTM)	24.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	1.13
52W Performance	44.4%	-16.0%
YTD Performance	2.2%	46.8%
% from 52W High	-37.3%	-18.3%
% from 52W Low	51.8%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-9.0%
Earnings Yield (TTM)	14.4%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View ORIC research

Valuation

P/E Ratio

ANAB

14.99x

P/S Ratio

ORIC

0.00x

ANAB

5.73x

EV/FCF

ORIC

-10.72x

ANAB

82.17x

Growth & revenue

Revenue Growth TTM

ANAB

92.9%

Forward Revenue Growth

ORIC

1520.7%

ANAB

34.7%

Profitability & performance

Gross Margin

ANAB

0.0%

ORIC

0.0%

ROE

ANAB

895.0%

ORIC

-3535.0%

FCF Yield %

ANAB

1.3%

ORIC

-9.0%

52-Week Performance

ANAB

44.4%

ORIC

-16.0%

Detailed metrics comparison

ANAB

AnaptysBio Inc

ORIC

Oric Pharmaceuticals Inc

Market Cap

ANAB$1.36B

ORIC$1.24B

Enterprise Value

ANAB$1.48B

ORIC$1.20B

Price

ANAB$45.95

ORIC$11.99

P/E Ratio

ANAB14.99x

ORICN/A

P/S Ratio

ANAB5.73x

ORIC0.00x

EV/Sales

ANAB6.24x

ORIC0.00x

EV/EBITDA

ANAB10.83x

ORIC0.00x

P/B Ratio

ANAB137.06x

ORIC3.32x

P/FCF Ratio

ANAB75.37x

ORICN/A

EV/FCF

ANAB82.17x

ORIC-10.72x

PEG Ratio

ANABN/A

ORICN/A

Forward P/E (NTM)

ANAB16.38x

ORICN/A

Forward P/S (NTM)

ANAB10.95x

ORICN/A

Revenue (TTM)

ANAB$238M

ORIC$0

Revenue Growth (YoY)

ANAB92.9%

ORICN/A

Forward Rev Growth

ANAB34.7%

ORIC1520.7%

Gross Margin (TTM)

ANAB0.0%

ORIC0.0%

Operating Margin (TTM)

ANAB56.4%

ORIC0.0%

EBITDA Margin (TTM)

ANAB56.5%

ORIC0.0%

Net Margin (TTM)

ANAB82.4%

ORIC0.0%

FCF Margin (TTM)

ANAB7.6%

ORICN/A

Net Income (TTM)

ANAB$196M

ORIC$-140M

FCF (TTM)

ANAB$18M

ORIC$-112M

EPS (TTM)

ANAB$3.07

ORIC-$1.30

ROE (TTM)

ANAB895.0%

ORIC-3535.0%

ROA (TTM)

ANAB57.4%

ORIC-3339.0%

ROIC (TTM)

ANAB63.2%

ORIC-3535.0%

Cash

ANAB$134M

ORIC$37M

Debt

ANAB$256M

ORIC$0

Net Cash/Debt

ANAB$-123M

ORIC$37M

Current Ratio (TTM)

ANAB5.61x

ORIC13.19x

Quick Ratio (TTM)

ANAB5.54x

ORIC12.76x

Debt/Equity (TTM)

ANAB24.23x

ORIC0.00x

Debt/Assets (TTM)

ANAB0.0%

ORIC0.0%

Interest Coverage (TTM)

ANABN/A

ORICN/A

Net Debt/EBITDA (TTM)

ANAB0.00x

ORIC0.00x

Beta

ANAB0.82

ORIC1.13

52W Performance

ANAB44.4%

ORIC-16.0%

YTD Performance

ANAB2.2%

ORIC46.8%

% from 52W High

ANAB-37.3%

ORIC-18.3%

% from 52W Low

ANAB51.8%

ORIC65.8%

Asset Turnover (TTM)

ANAB0.70x

ORIC0.00x

FCF Yield (TTM)

ANAB1.3%

ORIC-9.0%

Earnings Yield (TTM)

ANAB14.4%

ORIC-11.3%

Dividend Yield (TTM)

ANABN/A

ORICN/A

Rule of 40

ANAB100.5

ORIC0.0

EV/GP/RG

ANABN/A

ORICN/A

Ticker research

View ANAB research View ORIC research

Metric	ANAB AnaptysBio Inc	ORIC Oric Pharmaceuticals Inc
Market & Valuation
Market Cap	$1.36B	$1.24B
Enterprise Value	$1.48B	$1.20B
Price	$45.95	$11.99
P/E Ratio	14.99x	N/A
P/S Ratio	5.73x	0.00x
EV/Sales	6.24x	0.00x
EV/EBITDA	10.83x	0.00x
P/B Ratio	137.06x	3.32x
P/FCF Ratio	75.37x	N/A
EV/FCF	82.17x	-10.72x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	16.38x	N/A
Forward P/S (NTM)	10.95x	N/A
Revenue & Growth
Revenue (TTM)	$238M	$0
Revenue Growth (YoY)	92.9%	N/A
Forward Rev Growth	34.7%	1520.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	56.4%	0.0%
EBITDA Margin (TTM)	56.5%	0.0%
Net Margin (TTM)	82.4%	0.0%
FCF Margin (TTM)	7.6%	N/A
Net Income (TTM)	$196M	$-140M
FCF (TTM)	$18M	$-112M
EPS (TTM)	$3.07	-$1.30
ROE (TTM)	895.0%	-3535.0%
ROA (TTM)	57.4%	-3339.0%
ROIC (TTM)	63.2%	-3535.0%
Financial Health
Cash	$134M	$37M
Debt	$256M	$0
Net Cash/Debt	$-123M	$37M
Current Ratio (TTM)	5.61x	13.19x
Quick Ratio (TTM)	5.54x	12.76x
Debt/Equity (TTM)	24.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.82	1.13
52W Performance	44.4%	-16.0%
YTD Performance	2.2%	46.8%
% from 52W High	-37.3%	-18.3%
% from 52W Low	51.8%	65.8%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.00x
FCF Yield (TTM)	1.3%	-9.0%
Earnings Yield (TTM)	14.4%	-11.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	100.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANAB research	View ORIC research